Epigenetic Clock Analysis for Biological Age and Age Acceleration Research
When chronological age does not explain why participants, tissues, or study groups show different aging trajectories, DNA methylation–based clocks provide a quantitative research endpoint. Our Epigenetic Clock Analysis service estimates DNAm age, age acceleration or deceleration, and pace-of-aging metrics using models selected for the sample type, platform, and study objective.
From study design and methylation profiling to model computation, statistical comparison, and research-ready reporting, CD Genomics helps aging, disease, exposure, and intervention studies move from methylation data to interpretable cohort-level evidence.
Key Advantages of Our Epigenetic Clock Analysis:
- Question-Led Clock Selection: Match chronological-age, healthspan-related, mortality-related, or pace-of-aging metrics to the actual study endpoint.
- Flexible Project Entry: Start with biological samples, extracted DNA, or compatible methylation data from an existing cohort.
- Platform-Aware Quality Control: Review required CpG coverage, preprocessing, batch structure, and sample suitability before clock interpretation.
- Research-Ready Outputs: Receive sample-level clock metrics, statistical comparisons, figures, and documented model settings for downstream research.
What We Do: Estimate Biological Age and Age Acceleration
Epigenetic clock analysis converts age-associated DNA methylation patterns into study-level aging metrics. Depending on the research question, the analysis can estimate DNA methylation age, calculate the difference or residual between methylation age and chronological age, compare aging metrics across groups, or quantify the pace of biological aging.
CD Genomics supports projects that begin with genomic DNA, biospecimens, or compatible methylation data. The analytical route is selected before processing so that the assay, clock model, tissue source, covariates, and planned comparison address the same biological question.
Generate sample-level DNAm age values with a clock appropriate for the tissue and methylation platform, enabling direct comparison with chronological age.
Calculate age deviation or regression-based acceleration metrics so groups and covariates can be compared on a consistent statistical basis.
Summarize distributions, subgroup effects, associations, and longitudinal changes to show where aging signals differ within the study design.
Why this matters: a clock score is useful only when its biological meaning matches the study endpoint. A chronological-age clock, a healthspan-oriented clock, and a pace-of-aging measure answer different questions; selecting the model first prevents technically valid data from being interpreted against the wrong endpoint.
Projects that also require genome-wide locus discovery can be paired with our genome-wide DNA methylation analysis service. Studies focused on population-scale array profiling may use our human DNA methylation microarray service.
Research Applications of Epigenetic Clock Analysis
Epigenetic clock analysis is most informative when the selected metric is connected to a defined comparison, exposure, phenotype, or time point. The following applications show what evidence the service can provide and how that evidence supports the next research decision.
When researchers need to determine whether a tissue or study group shows aging beyond chronological expectations, DNAm age and age-acceleration metrics provide a quantitative comparison. These results help identify groups and covariates for deeper mechanistic investigation.
When disease status, severity, or progression may be associated with altered aging, clock scores can be compared across cases, controls, and clinical research strata. This helps determine whether epigenetic aging is associated with the phenotype and whether the signal remains after relevant covariates are considered.
When an intervention is expected to influence biological aging, baseline and follow-up clock metrics can quantify the direction and magnitude of within-person or between-group change. These results support research evaluation of the intervention while avoiding claims that a clock shift alone proves rejuvenation.
When exposure history or lifestyle factors may affect aging trajectories, age-acceleration or pace metrics can be tested against dose, duration, and covariates. This helps prioritize exposures and subgroups for follow-up methylation or functional studies.
When the objective is to measure change within the same participants, repeated methylation profiles can be analyzed with time-aware models. This separates within-person trajectories from cross-sectional differences and complements our longitudinal DNA methylation research solution.
When established clocks do not fit a species, tissue, assay, or endpoint, selected CpG features and training data can support custom model development or independent validation. This provides a route from discovery data to a defined, testable clock model.
Choose the Right Epigenetic Clock for Your Study
Clock choice should follow the research endpoint, tissue source, age range, and data platform. Using several clocks can be informative when they represent complementary aging constructs, but reporting more scores does not automatically produce a stronger conclusion.
Choose the Right Assay Route
| Assay Route | Best For | Key Limitation |
|---|---|---|
| Human methylation array | Cohort studies requiring multiple clocks, EWAS, or age-acceleration analysis | Human-specific; not every historical clock has complete probe compatibility on every array generation |
| Targeted clock assay | Focused, high-throughput age estimation using a defined CpG panel | Limited to the tissue and population for which the targeted model was validated |
| Mouse or mammalian array | Mouse studies, preclinical research, and comparative mammalian aging | Requires species-, tissue-, and platform-compatible clock models |
| Existing-data analysis | Reanalysis of completed methylation-array or sequencing projects | Feasibility depends on raw-data availability and coverage of the CpGs required by the selected clock |
Before analysis, we review whether the CpG loci required by the selected clock are present on the submitted platform. Missing probes, array-version differences, or undocumented preprocessing can prevent some clocks from being calculated reliably.
Best fit: epigenetic clock analysis is appropriate when the study has compatible methylation data, chronological age or relevant outcome metadata, and a defined cohort-level hypothesis.
Not the best fit: a clock score alone is not designed to identify causal methylation loci or prove that an intervention reversed aging. Use genome-wide discovery when the goal is to find differential loci, or a targeted DNA methylation analysis service when specific markers require focused validation.
| Clock or Metric | Primary Research Focus | Important Selection Note |
|---|---|---|
| Horvath clock | Chronological-age estimation across multiple human tissues and cell types | Useful for multi-tissue studies when the required loci and platform are compatible |
| Hannum clock | Chronological-age estimation from whole-blood methylation data | Most relevant to blood-based cohorts and should not be treated as a universal tissue clock |
| PhenoAge | Phenotypic aging and healthspan-related research | Selected when the study question extends beyond prediction of chronological age |
| GrimAge | Mortality- and morbidity-related risk research in blood-based cohorts | Interpretation should remain aligned with its training targets and study population |
| DunedinPACE | Pace of biological aging rather than accumulated biological age | Useful when the research endpoint concerns how rapidly aging processes are progressing |
| Custom clock | Species-, tissue-, assay-, or endpoint-specific model development | Requires suitable training and validation data; performance must be evaluated outside the training set |
How Our Epigenetic Clock Analysis Workflow Works
The workflow begins with the research endpoint, not with a default clock. We align the clock model, sample source, methylation assay, covariates, and comparison plan before data generation, then carry the agreed design through quality control, computation, statistical analysis, and reporting.
1. Study design and clock selection – Define the biological question, tissue, cohort structure, time points, metadata, and candidate clock models.
2. Sample or data review – Check sample suitability or assess existing array, sequencing, and metadata files for model compatibility.
3. DNA methylation profiling – Generate methylation data with the selected array or sequencing route when raw biospecimens or DNA are submitted.
4. Data preprocessing and quality control – Review sample identity, signal quality, missingness, normalization, batch structure, and probe or locus compatibility.
5. Clock computation and statistical analysis – Calculate selected clock metrics and compare them across groups, covariates, or time points.
6. Results review and delivery – Deliver tables, figures, methods, and study-level interpretation with documented model and analysis settings.
What We Analyze: DNAm Age, Age Acceleration, and Group Differences
Our analysis separates data quality, clock computation, and biological comparison so clients can see how each reported metric was produced. Standard modules are selected according to the model and study design; advanced association or longitudinal analyses can be added when the metadata support them.
Evaluate signal quality, missing data, sample relationships, normalization, batch structure, and the availability of CpG loci required by the selected clock. Platform-aware preprocessing reduces technical variation before age metrics are compared, which improves confidence that observed group differences are not driven by assay artifacts.
Calculate DNAm age or pace-of-aging scores using the agreed model and compatible loci. Recording the exact clock version, input transformation, and missing-probe handling makes the analysis reproducible and helps clients compare results across studies.
Derive difference-based or regression-residual measures and clearly state which definition is used. This prevents different acceleration metrics from being treated as interchangeable and gives study teams a defensible endpoint for group or exposure analysis.
Compare clock metrics across experimental groups, phenotypes, exposures, treatments, or repeated time points, with relevant covariates incorporated when available. Optional analyses can include subgroup assessment, sensitivity analysis, and associations with molecular or phenotypic variables.
What You Receive: Epigenetic Age Results and Research-Ready Outputs
Each project is delivered as a traceable set of sample-level metrics, quality-control summaries, visualizations, and analysis records. The package is designed to support immediate scientific review and downstream statistical or manuscript work.
| Output | What It Contains | How It Supports Your Study |
|---|---|---|
| Sample-level clock table | Chronological age, selected clock score, DNAm age, and derived acceleration or pace metrics as applicable | Provides analysis-ready endpoints for cohort, group, or longitudinal comparisons |
| Quality-control summary | Sample and signal checks, normalization review, locus compatibility, and exclusions with reasons | Shows which samples support reliable clock calculation and why |
| Statistical results | Group contrasts, covariate associations, model estimates, and significance summaries defined in the analysis plan | Connects aging metrics to the study hypothesis rather than reporting scores in isolation |
| Figures | Observed-versus-predicted plots, distributions, subgroup comparisons, and longitudinal or association plots when applicable | Makes model behavior and biological differences easier to review and communicate |
| Methods and parameter record | Clock version, preprocessing decisions, metric definitions, software settings, and analysis notes | Supports reproducibility and consistent interpretation across collaborators |
Final deliverables depend on the selected clock, input data type, sample quality, study design, and agreed statistical scope.
Sample and Data Requirements for Epigenetic Clock Analysis
Projects may start from biological material, extracted genomic DNA, or existing DNA methylation data. The most suitable submission route depends on the species, tissue type, selected assay, clock model, and sample condition.
| Project Route | Accepted Input | Planning Reference | Key Requirement |
|---|---|---|---|
| Human array-based analysis | Genomic DNA from whole blood, buffy coat, saliva, buccal samples, fresh/frozen tissue, or FFPE tissue | 500 ng DNA preferred; 250 ng minimum for compatible array workflows | Tissue source, platform, sample quality, and selected clock must be compatible |
| Human targeted-clock analysis | Extracted genomic DNA from a sample type validated for the selected clock | Typically 200–250 ng DNA | Blood-, urine-, and buccal-based clocks are tissue-specific and should not be used interchangeably |
| Mouse clock analysis | Genomic DNA, whole blood, liver, muscle, brain tissue, or selected cell samples | Approximately 250 ng DNA as a planning reference | Mouse strain, tissue, treatment design, and selected model should be reviewed together |
| Other mammalian analysis | Extracted DNA or tissue from a mammalian species | Project-dependent | Requires a species-specific or pan-mammalian clock and compatible CpG coverage |
| Existing-data analysis | Raw IDAT, FASTQ, or complete methylation matrices | No new biological sample required | Feasibility depends on the platform, preprocessing history, and coverage of CpG loci required by the selected clock |
Values are general planning references. Final requirements depend on the selected assay, clock model, species, tissue type, and sample condition.
Species and Clock Compatibility
Epigenetic clock analysis is not limited to human cohorts, but the clock model, tissue, methylation assay, and validation dataset must be compatible with the species. Human clock formulas should not be applied directly to non-human samples.
| Species Scope | Service Positioning | Important Requirement |
|---|---|---|
| Human | Standard service scope | Select a clock compatible with the tissue, platform, cohort age range, and research endpoint |
| Mouse | Standard or project-specific scope | Mouse strain, tissue, intervention design, and clock validation should be considered together |
| Rat and other mammals | Feasibility review required | Use a species-specific or pan-mammalian route according to the available platform, tissue, and clock model |
| Selected tissues and cell samples | Project-specific scope | Availability depends on a tissue-appropriate clock or a customized project design and should be reviewed before submission |
Non-mammalian projects are not included in the standard service scope and require a separate feasibility assessment.
Why Choose CD Genomics for Epigenetic Clock Analysis
Our service connects the assay route, clock model, quality control, statistical analysis, and deliverables in one project plan. This helps ensure that the reported aging metric is appropriate for the submitted species, tissue, platform, and research endpoint.
Human methylation arrays, targeted assays, mouse or mammalian platforms, and existing-data analysis are selected according to the model and sample type. Required CpG coverage is reviewed before clock computation.
Chronological-age, healthspan-related, mortality-related, and pace-of-aging clocks are not interchangeable. We select a primary model and, when useful, complementary models based on the tissue, species, cohort, and endpoint.
Analysis can include methylation quality control, normalization review, Clock computation, age-acceleration metrics, and comparisons across groups, exposures, interventions, phenotypes, or time points.
Projects can begin with biospecimens, extracted DNA, or compatible methylation files. Delivery can include sample-level metrics, QC summaries, statistical results, figures, and documented model settings.
Case Study: Building a Minimized Epigenetic Clock
FAQ About Epigenetic Clock Analysis
References
- Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14:R115.
- Hannum G, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Molecular Cell. 2013;49:359–367.
- Levine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10:573–591.
- Lu AT, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11:303–327.
- Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420.
- Romanov SE, et al. A Novel Framework for the Design of Minimized Epigenetic Clocks Using the Analysis of DNA Methylation Heterogeneity. International Journal of Molecular Sciences. 2025;26:5051.
For research use only. Not for use in diagnostic procedures or individual healthcare decisions.
Interested in seeing a sample project report? Complete the form below and our team will send the requested demo report to your email.